The real-world cost and health resource utilization associated to the CNIC-polypill containing Atorvastatin 20mg in secondary prevention patients: a subanalysis of the NEPTUNO study
Real-world early effectiveness and safety of inclisiran in China Pilot Zone: An interim analysis of 3-month data from a prospective non-interventional cohort study